Aug. 3 at 7:03 AM
$CNTB 2 bucks,
For Rademikibart that has created a completely new therapeutic Class
Hyper -acute Respiratory Biologic.
When you bypass the maintenance timeline of Dupixent dominance &
capture the immediate point-of care network from the ER w a 300mg IV Push,& stuff a prescription of Rademikibart 600mg for monthly maintenance the addressable financial premium skyrockets.
Rademikibart will literally be a Closed Loop Respiratory Franchise that also has Best in Class Eczema data, all this for 2 fkn bucks.
Ciao' 😏
